One of the chemopreventive approaches to cancer development is the administration of non-steroidal anti-inflammatory drugs (NSAIDs), such as celecoxib (Cx), which are inhibitors of cyclooxygenase 2 (COX-2). Here, PTGS2 is linked to cancer.